**Figure 3.** Fig 2. Clinical decision algorithm for choosing an appropriate probiotic product. https://doi.org/10.1371/journal.pone.0209205.g002

Descrizione

A clinical decision algorithm guides clinicians through the process of selecting an appropriate probiotic product based on the patient's specific condition, available evidence for particular strains, and practical considerations such as product availability and cost.

More Figures from This Paper

Figure 2

A PRISMA flow diagram details the systematic literature search and study selection process for evaluating probiotic efficacy across multiple clinical conditions. Studies are screened from inception through defined databases with specific inclusion and exclusion criteria.

flowchart

Figure 3

Flowchart

1044 × 882px · 325,1 KB

Source Paper

Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.

PloS one (2018)

PMID: 30586435

DOI: 10.1371/journal.pone.0209205

Cite This Figure

![Figure 3: A clinical decision algorithm guides clinicians through the process of selecting an appropriate probiotic product based on the patient's specific condition, available evidence for particular strains, and practical considerations such as product availability and cost.](https://pdfs.citedhealth.com/figures/30586435/458.png)

> Source: Jason C Sniffen et al. "Choosing an appropriate probiotic product for your patient: An evidence-based pr." *PloS one*, 2018. PMID: [30586435](https://pubmed.ncbi.nlm.nih.gov/30586435/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/30586435/458.png" alt="A clinical decision algorithm guides clinicians through the process of selecting an appropriate probiotic product based on the patient's specific condition, available evidence for particular strains, and practical considerations such as product availability and cost." />
  <figcaption>Figure 3. A clinical decision algorithm guides clinicians through the process of selecting an appropriate probiotic product based on the patient's specific condition, available evidence for particular strains, and practical considerations such as product availability and cost.<br>  Source: Jason C Sniffen et al. "Choosing an appropriate probiotic product for your patient: An evidence-based pr." <em>PloS one</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30586435/">30586435</a></figcaption>
</figure>

Evidenze correlate

Saccharomyces boulardii per Antibiotic-Associated Diarrhea (AAD)

Grado A · 25 studi

Saccharomyces boulardii per Traveler's Diarrhea

Grado B · 4 studi